investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanism of Meiotic Recombination
Michael Lichten
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Alastair Goldman
University of Sheffield
Sheffield, United Kingdom
Alain Nicolas
Institute Curie
Paris, France
Michael Lichten
National Cancer Institute (NIH)
Rockville, United States
Related projects
Dominique C Bergmann
Control of epidermal self-renewing populations by bHLH and MAPK regulatory system
All cancers but non-melanoma skin cancer
Alfred Singer
Specification of T Cell Function During Development
All cancers but non-melanoma skin cancer
David Hammond
Evaluating the Impact of Mandatory Nutrition Information on Menus
All cancers but non-melanoma skin cancer
Pediatric oncology or childhood cancer
Xiongbin Lu
Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling
All cancers but non-melanoma skin cancer
Renato V Iozzo
The Biology of Perlecan in Cancer and Angiogenesis
All cancers but non-melanoma skin cancer
Peter R Parham
Interactions Between HLA Class I and Cytolytic Lymphocytes
All cancers but non-melanoma skin cancer
Christine Mayr
Dissecting the role of alternative 3UTRs in cancer with 3-seq
All cancers but non-melanoma skin cancer
Pathology
Amy Shaub Maddox
Molecular mechanisms of cell shape change in cytokinesis
All cancers but non-melanoma skin cancer
Alice Hooper
Synthesis and biological evaluation of CRAF inhibitors
All cancers but non-melanoma skin cancer